How autophagy shapes the lymphatic system

Our lymphatic vasculature is part of our circulatory system and it carries 'lymph' through our body. This is crucial to maintain internal fluid levels, transport immune cells to their location, and for fat absorption. New work by the team of Prof. Patrizia Agostinis (VIB-KU Leuven Center for Cancer Biology and the Department of Cellular and Molecular Medicine at KU Leuven) shows how autophagy shapes our lymphatic system. Their results appear in the journal Nature Communications.

Facts about the lymphatic system 

  • Starts developing around the fifth week of embryonic development ​ 
  • In adults, problems with the lymphatic vessels can lead to fluid retention, which manifests as tissue swelling (lymphedema) and impaired wound healing 
  • The excessive formation of new lymphatic vessels (called lymphangiogenesis) can favor the spread of cancer ​ 
  • The lymph nodes in our body serve as battlefields for our immune system to remove toxins, waste, and pathogens 
  • An increasing number of human diseases are linked to dysfunctions of the lymphatic system 

The importance of autophagy 

Autophagy (literally 'self-eating') is the major mechanism for getting rid of damaged or old cell materials by taking them to the lysosomes. These lysosomes are cellular structures in which damaged cell components are broken down and recycled as a source of energy. This is good for us because it helps our body get rid of damaged cellular components and pathogens, and it makes sure that all of our cells and tissues function well, especially when nutrients are scarce. 

The team of Prof. Patrizia Agostinis (VIB-KU Leuven Center for Cancer Biology and the Department of Cellular and Molecular Medicine at KU Leuven) now demonstrates that autophagy is also vital for the lymphatic system. Using both human cell lines and lab mice, the researchers show that autophagy is a critical process for the growth of the lymphatic vessels in response to injury-causing inflammation. Losing the capacity for autophagy in the lymphatic vessels impairs their ability to respond to growth-stimulating factors. 

Fatty acids and mitochondria 

Agostinis: "It was clear that autophagy had a large effect on wound-healing and inflammation, but we wanted to discover how this happened. Because lymphatic vessels are specialized in absorbing and moving around fatty acids, and they ‘eat’ fat as nutrients for their growth, that's where we started." 

It was a good call. 

The team found that autophagy in the lymphatic endothelial cells – the building blocks of the lymphatic vessels – controls the breakdown and recycling of specific vesicles, called lipid droplets, where fats are stored within the cell before they can be used as nutrients in metabolism. A selective autophagy process – termed lipophagy – then cuts up these vesicles and frees the nutrients for the powerhouses of our cells, the mitochondria. Once delivered to the mitochondria, the fatty acids are used to produce energy and much more. ​ 

The mitochondrial network (blue) with lipid droplets (purple) of a lymphatic endothelial cell (Meçe, Houbaert, et al. Nature Communications 2022)

The use of these nutrients by the mitochondria also generates molecules that instruct the nucleus of the cells to keep up the expression levels of VEGFR3. This is a crucial receptor that, when stimulated by the protein VEGF-C, tells the lymphatics to proliferate and migrate to form new vessels. When autophagy in the lymphatic endothelial cells does not work, the fatty acids don't make it to the mitochondria. Result? The lymphatic vessels can’t eat their fatty meal and do not grow in response to a traumatic injury. ​ 

Dr. Odeta Meçe, co-first author of the study: "We also show that supplementing mice with acetate, a fatty acid precursor that the mitochondria can directly use, restores the growth of lymphatic vessels - even when autophagy is not functioning well.” ​ 

Diede Houbaert, PhD student and co-first author, adds: "Our findings further emphasize the vital connection between mitochondria fatty acid metabolism and lymphatic vessels growth recently highlighted by the group of Prof. Peter Carmeliet.” ​ 

Agostinis “The link between autophagy and lymphatics is intriguing also considering that a high-fat, low carbohydrate ketogenic diet and physical exercise alleviate lymphedema by stimulating the formation of lymphatic vessels are well-known stimulators of autophagy. Future studies are needed to better understand whether and how pharmacological modulation of autophagy might normalize dysfunctional lymphatic vessels in lymphedema and other critical disease conditions." 

 

Lipid Droplets Degradation by Autophagy Connects Mitochondria Metabolism to PROX1-driven Expression of Lymphatic Genes and Lymphangiogenesis 

Meçe, Houbaert, et al. Nature Communications 2022 

 

Questions from patients 

A breakthrough in research is not the same as a breakthrough in medicine. The realizations of VIB researchers can form the basis of new therapies, but the development path still takes years. This can raise a lot of questions. That is why we ask you to please refer questions in your report or article to the email address that VIB makes available for this purpose: patienteninfo@vib.be. Everyone can submit questions concerning this and other medically-oriented research directly to VIB via this address. 

 

Gunnar De Winter

Gunnar De Winter

Science Communications Expert, VIB

 

Share

Latest stories

Website preview
Blocking lipid production in healthy lung cells can reduce lung metastasis
Leuven, 17 March 2026 - Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs. In two complementary studies published in Nature Cell Biology and Cancer Discovery, they show that tumors use lipids produced by lung cells as signals, and that decreasing the lipid production of lung cells can decrease metastasis. The findings point to new therapeutic strategies that target lung cell lipid production, rather than cancer cells themselves, which may also help refine patient selection for ongoing clinical trials targeting this pathway.
press.vib.be
Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be